nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—Transaminitis—Thiotepa—urinary bladder cancer	0.0507	0.144	CcSEcCtD
Fomepizole—CYP2A6—Fluorouracil—urinary bladder cancer	0.0441	0.645	CbGbCtD
Fomepizole—Transaminitis—Gemcitabine—urinary bladder cancer	0.0426	0.121	CcSEcCtD
Fomepizole—CYP2E1—Etoposide—urinary bladder cancer	0.0243	0.355	CbGbCtD
Fomepizole—Phlebosclerosis—Epirubicin—urinary bladder cancer	0.0204	0.0579	CcSEcCtD
Fomepizole—Phlebosclerosis—Doxorubicin—urinary bladder cancer	0.0189	0.0536	CcSEcCtD
Fomepizole—ADH1A—prostate gland—urinary bladder cancer	0.0173	0.0772	CbGeAlD
Fomepizole—ADH1C—prostate gland—urinary bladder cancer	0.0169	0.0757	CbGeAlD
Fomepizole—CAT—prostate gland—urinary bladder cancer	0.0133	0.0594	CbGeAlD
Fomepizole—ADH1B—prostate gland—urinary bladder cancer	0.012	0.0535	CbGeAlD
Fomepizole—ADH1C—urethra—urinary bladder cancer	0.0113	0.0507	CbGeAlD
Fomepizole—CAT—seminal vesicle—urinary bladder cancer	0.0112	0.0502	CbGeAlD
Fomepizole—CAT—Podofilox—Etoposide—urinary bladder cancer	0.0111	1	CbGdCrCtD
Fomepizole—Lymphangitis—Epirubicin—urinary bladder cancer	0.0104	0.0294	CcSEcCtD
Fomepizole—ADH1B—seminal vesicle—urinary bladder cancer	0.0101	0.0452	CbGeAlD
Fomepizole—CAT—epithelium—urinary bladder cancer	0.00977	0.0436	CbGeAlD
Fomepizole—Lymphangitis—Doxorubicin—urinary bladder cancer	0.00959	0.0272	CcSEcCtD
Fomepizole—CAT—smooth muscle tissue—urinary bladder cancer	0.00941	0.042	CbGeAlD
Fomepizole—CAT—renal system—urinary bladder cancer	0.00906	0.0405	CbGeAlD
Fomepizole—CAT—urethra—urinary bladder cancer	0.0089	0.0397	CbGeAlD
Fomepizole—ADH1C—vagina—urinary bladder cancer	0.00836	0.0374	CbGeAlD
Fomepizole—ADH1B—renal system—urinary bladder cancer	0.00816	0.0364	CbGeAlD
Fomepizole—CYP2E1—urine—urinary bladder cancer	0.00796	0.0355	CbGeAlD
Fomepizole—Injection site inflammation—Thiotepa—urinary bladder cancer	0.00727	0.0206	CcSEcCtD
Fomepizole—CAT—female reproductive system—urinary bladder cancer	0.00725	0.0324	CbGeAlD
Fomepizole—CAT—vagina—urinary bladder cancer	0.00656	0.0293	CbGeAlD
Fomepizole—ADH1B—female reproductive system—urinary bladder cancer	0.00653	0.0292	CbGeAlD
Fomepizole—CYP2A6—prostate gland—urinary bladder cancer	0.00604	0.027	CbGeAlD
Fomepizole—ADH1B—vagina—urinary bladder cancer	0.00591	0.0264	CbGeAlD
Fomepizole—ADH1A—lymph node—urinary bladder cancer	0.00551	0.0246	CbGeAlD
Fomepizole—Phlebitis—Carboplatin—urinary bladder cancer	0.00546	0.0155	CcSEcCtD
Fomepizole—ADH1C—lymph node—urinary bladder cancer	0.00541	0.0242	CbGeAlD
Fomepizole—CYP2A6—seminal vesicle—urinary bladder cancer	0.00511	0.0228	CbGeAlD
Fomepizole—Application site reaction—Fluorouracil—urinary bladder cancer	0.00428	0.0121	CcSEcCtD
Fomepizole—CAT—lymph node—urinary bladder cancer	0.00424	0.019	CbGeAlD
Fomepizole—Transaminases increased—Thiotepa—urinary bladder cancer	0.00399	0.0113	CcSEcCtD
Fomepizole—ADH1B—lymph node—urinary bladder cancer	0.00382	0.0171	CbGeAlD
Fomepizole—Transaminases increased—Gemcitabine—urinary bladder cancer	0.00335	0.00952	CcSEcCtD
Fomepizole—Taste metallic—Methotrexate—urinary bladder cancer	0.00328	0.00932	CcSEcCtD
Fomepizole—Anuria—Methotrexate—urinary bladder cancer	0.00299	0.00848	CcSEcCtD
Fomepizole—CYP2A6—vagina—urinary bladder cancer	0.00298	0.0133	CbGeAlD
Fomepizole—Back pain—Valrubicin—urinary bladder cancer	0.00296	0.00841	CcSEcCtD
Fomepizole—Injection site inflammation—Epirubicin—urinary bladder cancer	0.00293	0.00831	CcSEcCtD
Fomepizole—Heartburn—Fluorouracil—urinary bladder cancer	0.00292	0.00828	CcSEcCtD
Fomepizole—CYP2E1—prostate gland—urinary bladder cancer	0.00286	0.0128	CbGeAlD
Fomepizole—Anaemia—Valrubicin—urinary bladder cancer	0.00283	0.00803	CcSEcCtD
Fomepizole—Nystagmus—Fluorouracil—urinary bladder cancer	0.00281	0.00797	CcSEcCtD
Fomepizole—Anuria—Epirubicin—urinary bladder cancer	0.0028	0.00794	CcSEcCtD
Fomepizole—Injection site inflammation—Doxorubicin—urinary bladder cancer	0.00271	0.00769	CcSEcCtD
Fomepizole—Drowsiness—Mitomycin—urinary bladder cancer	0.0027	0.00766	CcSEcCtD
Fomepizole—Anuria—Doxorubicin—urinary bladder cancer	0.00259	0.00734	CcSEcCtD
Fomepizole—CYP2E1—seminal vesicle—urinary bladder cancer	0.00242	0.0108	CbGeAlD
Fomepizole—CAT—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00211	0.00613	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00204	0.0058	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.00201	0.00585	CbGpPWpGaD
Fomepizole—Vision blurred—Mitomycin—urinary bladder cancer	0.00199	0.00564	CcSEcCtD
Fomepizole—Pain—Carboplatin—urinary bladder cancer	0.00198	0.00562	CcSEcCtD
Fomepizole—Abdominal pain—Valrubicin—urinary bladder cancer	0.00197	0.00561	CcSEcCtD
Fomepizole—Body temperature increased—Valrubicin—urinary bladder cancer	0.00197	0.00561	CcSEcCtD
Fomepizole—Anaemia—Mitomycin—urinary bladder cancer	0.00195	0.00553	CcSEcCtD
Fomepizole—CYP2E1—renal system—urinary bladder cancer	0.00195	0.0087	CbGeAlD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00193	0.00561	CbGpPWpGaD
Fomepizole—CYP2E1—urethra—urinary bladder cancer	0.00191	0.00854	CbGeAlD
Fomepizole—Hiccups—Cisplatin—urinary bladder cancer	0.0019	0.0054	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00186	0.0054	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00184	0.00535	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—HPGDS—urinary bladder cancer	0.00183	0.00532	CbGpPWpGaD
Fomepizole—Body temperature increased—Carboplatin—urinary bladder cancer	0.00183	0.00519	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—SOD2—urinary bladder cancer	0.00178	0.00517	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—GSTT1—urinary bladder cancer	0.00178	0.00516	CbGpPWpGaD
Fomepizole—Diarrhoea—Valrubicin—urinary bladder cancer	0.00171	0.00485	CcSEcCtD
Fomepizole—Shock—Mitomycin—urinary bladder cancer	0.00169	0.00481	CcSEcCtD
Fomepizole—Dizziness—Valrubicin—urinary bladder cancer	0.00165	0.00469	CcSEcCtD
Fomepizole—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—urinary bladder cancer	0.00163	0.00472	CbGpPWpGaD
Fomepizole—Transaminases increased—Epirubicin—urinary bladder cancer	0.00161	0.00456	CcSEcCtD
Fomepizole—Phlebitis—Cisplatin—urinary bladder cancer	0.0016	0.00455	CcSEcCtD
Fomepizole—Vomiting—Valrubicin—urinary bladder cancer	0.00159	0.00451	CcSEcCtD
Fomepizole—CAT—FoxO family signaling—EP300—urinary bladder cancer	0.00158	0.00458	CbGpPWpGaD
Fomepizole—Rash—Valrubicin—urinary bladder cancer	0.00158	0.00447	CcSEcCtD
Fomepizole—Dermatitis—Valrubicin—urinary bladder cancer	0.00157	0.00447	CcSEcCtD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TNF—urinary bladder cancer	0.00157	0.00455	CbGpPWpGaD
Fomepizole—Headache—Valrubicin—urinary bladder cancer	0.00156	0.00444	CcSEcCtD
Fomepizole—CYP2E1—female reproductive system—urinary bladder cancer	0.00156	0.00696	CbGeAlD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00155	0.00451	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00153	0.00445	CbGpPWpGaD
Fomepizole—Somnolence—Mitomycin—urinary bladder cancer	0.00153	0.00434	CcSEcCtD
Fomepizole—Decreased appetite—Mitomycin—urinary bladder cancer	0.0015	0.00425	CcSEcCtD
Fomepizole—ADH1C—Biological oxidations—GSTP1—urinary bladder cancer	0.00149	0.00432	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GSTP1—urinary bladder cancer	0.00149	0.00432	CbGpPWpGaD
Fomepizole—Transaminases increased—Doxorubicin—urinary bladder cancer	0.00149	0.00422	CcSEcCtD
Fomepizole—Nausea—Valrubicin—urinary bladder cancer	0.00148	0.00421	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PLAU—urinary bladder cancer	0.00148	0.0043	CbGpPWpGaD
Fomepizole—Pain—Mitomycin—urinary bladder cancer	0.00147	0.00418	CcSEcCtD
Fomepizole—Phlebitis—Etoposide—urinary bladder cancer	0.00147	0.00417	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.00144	0.00418	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—ATM—urinary bladder cancer	0.0014	0.00408	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IL2—urinary bladder cancer	0.00138	0.00402	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—urinary bladder cancer	0.00138	0.00401	CbGpPWpGaD
Fomepizole—Nystagmus—Epirubicin—urinary bladder cancer	0.00137	0.00388	CcSEcCtD
Fomepizole—ADH1C—Biological oxidations—GSTM1—urinary bladder cancer	0.00137	0.00397	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GSTM1—urinary bladder cancer	0.00137	0.00397	CbGpPWpGaD
Fomepizole—Body temperature increased—Mitomycin—urinary bladder cancer	0.00136	0.00386	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—RBX1—urinary bladder cancer	0.00134	0.00389	CbGpPWpGaD
Fomepizole—Nystagmus—Doxorubicin—urinary bladder cancer	0.00127	0.00359	CcSEcCtD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00126	0.00365	CbGpPWpGaD
Fomepizole—CYP2A6—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00125	0.00364	CbGpPWpGaD
Fomepizole—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00125	0.00354	CcSEcCtD
Fomepizole—ADH1A—Biological oxidations—GSTP1—urinary bladder cancer	0.00123	0.00358	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00123	0.00356	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00121	0.00352	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00119	0.00344	CbGpPWpGaD
Fomepizole—Diarrhoea—Mitomycin—urinary bladder cancer	0.00118	0.00334	CcSEcCtD
Fomepizole—Dizziness—Mitomycin—urinary bladder cancer	0.00114	0.00323	CcSEcCtD
Fomepizole—ADH1A—Biological oxidations—GSTM1—urinary bladder cancer	0.00113	0.00329	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—RHOA—urinary bladder cancer	0.0011	0.00321	CbGpPWpGaD
Fomepizole—Vomiting—Mitomycin—urinary bladder cancer	0.00109	0.00311	CcSEcCtD
Fomepizole—Rash—Mitomycin—urinary bladder cancer	0.00109	0.00308	CcSEcCtD
Fomepizole—Dermatitis—Mitomycin—urinary bladder cancer	0.00108	0.00308	CcSEcCtD
Fomepizole—Headache—Mitomycin—urinary bladder cancer	0.00108	0.00306	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CDKN2A—urinary bladder cancer	0.00107	0.0031	CbGpPWpGaD
Fomepizole—Back pain—Thiotepa—urinary bladder cancer	0.00103	0.00291	CcSEcCtD
Fomepizole—Nausea—Mitomycin—urinary bladder cancer	0.00102	0.0029	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—ERBB2—urinary bladder cancer	0.00102	0.00297	CbGpPWpGaD
Fomepizole—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00102	0.00289	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—TNF—urinary bladder cancer	0.00101	0.00293	CbGpPWpGaD
Fomepizole—Pharyngitis—Fluorouracil—urinary bladder cancer	0.001	0.00284	CcSEcCtD
Fomepizole—Vision blurred—Thiotepa—urinary bladder cancer	0.000999	0.00284	CcSEcCtD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000994	0.00289	CbGpPWpGaD
Fomepizole—Anaemia—Thiotepa—urinary bladder cancer	0.00098	0.00278	CcSEcCtD
Fomepizole—Hiccups—Epirubicin—urinary bladder cancer	0.000977	0.00277	CcSEcCtD
Fomepizole—Agitation—Thiotepa—urinary bladder cancer	0.000975	0.00277	CcSEcCtD
Fomepizole—Bradycardia—Cisplatin—urinary bladder cancer	0.000972	0.00276	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—GSTP1—urinary bladder cancer	0.000951	0.00276	CbGpPWpGaD
Fomepizole—Visual impairment—Cisplatin—urinary bladder cancer	0.00092	0.00261	CcSEcCtD
Fomepizole—Convulsion—Thiotepa—urinary bladder cancer	0.000919	0.00261	CcSEcCtD
Fomepizole—ADH1C—Metabolism—GSTZ1—urinary bladder cancer	0.000911	0.00265	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTZ1—urinary bladder cancer	0.000911	0.00265	CbGpPWpGaD
Fomepizole—Hiccups—Doxorubicin—urinary bladder cancer	0.000904	0.00257	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CCND1—urinary bladder cancer	0.000903	0.00262	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CCNE1—urinary bladder cancer	0.0009	0.00261	CbGpPWpGaD
Fomepizole—Anxiety—Thiotepa—urinary bladder cancer	0.0009	0.00255	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—TP53—urinary bladder cancer	0.000889	0.00258	CbGpPWpGaD
Fomepizole—Flushing—Cisplatin—urinary bladder cancer	0.000886	0.00252	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—SOD2—urinary bladder cancer	0.000877	0.00255	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CDKN1A—urinary bladder cancer	0.000874	0.00254	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PTEN—urinary bladder cancer	0.000872	0.00253	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTO2—urinary bladder cancer	0.000864	0.00251	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTO2—urinary bladder cancer	0.000864	0.00251	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NAT1—urinary bladder cancer	0.000864	0.00251	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NAT1—urinary bladder cancer	0.000864	0.00251	CbGpPWpGaD
Fomepizole—Back pain—Gemcitabine—urinary bladder cancer	0.000863	0.00245	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000856	0.00249	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000846	0.00246	CbGpPWpGaD
Fomepizole—Tachycardia—Thiotepa—urinary bladder cancer	0.000845	0.0024	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—GPX1—urinary bladder cancer	0.000837	0.00243	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000833	0.00242	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—urinary bladder cancer	0.000828	0.0024	CbGpPWpGaD
Fomepizole—Vision blurred—Fluorouracil—urinary bladder cancer	0.000827	0.00235	CcSEcCtD
Fomepizole—Anaemia—Gemcitabine—urinary bladder cancer	0.000824	0.00234	CcSEcCtD
Fomepizole—Phlebitis—Epirubicin—urinary bladder cancer	0.000823	0.00234	CcSEcCtD
Fomepizole—CAT—Metabolism—GSTZ1—urinary bladder cancer	0.00082	0.00238	CbGpPWpGaD
Fomepizole—Flushing—Etoposide—urinary bladder cancer	0.000812	0.00231	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTO2—urinary bladder cancer	0.000812	0.00236	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—NAT1—urinary bladder cancer	0.000812	0.00236	CbGpPWpGaD
Fomepizole—Anaemia—Fluorouracil—urinary bladder cancer	0.000811	0.0023	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000801	0.00233	CbGpPWpGaD
Fomepizole—Visual disturbance—Methotrexate—urinary bladder cancer	0.000799	0.00227	CcSEcCtD
Fomepizole—ADH1C—Metabolism—UGT2B7—urinary bladder cancer	0.00079	0.00229	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—UGT2B7—urinary bladder cancer	0.00079	0.00229	CbGpPWpGaD
Fomepizole—Vision blurred—Cisplatin—urinary bladder cancer	0.000784	0.00222	CcSEcCtD
Fomepizole—CAT—Metabolism—GSTO2—urinary bladder cancer	0.000778	0.00226	CbGpPWpGaD
Fomepizole—CAT—Metabolism—NAT1—urinary bladder cancer	0.000778	0.00226	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000774	0.00225	CbGpPWpGaD
Fomepizole—Somnolence—Thiotepa—urinary bladder cancer	0.000769	0.00218	CcSEcCtD
Fomepizole—Anaemia—Cisplatin—urinary bladder cancer	0.000768	0.00218	CcSEcCtD
Fomepizole—Dyspepsia—Thiotepa—urinary bladder cancer	0.000762	0.00216	CcSEcCtD
Fomepizole—Phlebitis—Doxorubicin—urinary bladder cancer	0.000762	0.00216	CcSEcCtD
Fomepizole—Convulsion—Fluorouracil—urinary bladder cancer	0.00076	0.00216	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GSTZ1—urinary bladder cancer	0.000755	0.00219	CbGpPWpGaD
Fomepizole—Decreased appetite—Thiotepa—urinary bladder cancer	0.000752	0.00214	CcSEcCtD
Fomepizole—Dysgeusia—Etoposide—urinary bladder cancer	0.000746	0.00212	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000742	0.00216	CbGpPWpGaD
Fomepizole—Pain—Thiotepa—urinary bladder cancer	0.00074	0.0021	CcSEcCtD
Fomepizole—Back pain—Etoposide—urinary bladder cancer	0.000737	0.00209	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000727	0.00211	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—urinary bladder cancer	0.000724	0.0021	CbGpPWpGaD
Fomepizole—Convulsion—Cisplatin—urinary bladder cancer	0.00072	0.00205	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GSTO2—urinary bladder cancer	0.000716	0.00208	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NAT1—urinary bladder cancer	0.000716	0.00208	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP4B1—urinary bladder cancer	0.000711	0.00207	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP4B1—urinary bladder cancer	0.000711	0.00207	CbGpPWpGaD
Fomepizole—CAT—Metabolism—UGT2B7—urinary bladder cancer	0.000711	0.00207	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000708	0.00201	CcSEcCtD
Fomepizole—Anxiety—Cisplatin—urinary bladder cancer	0.000705	0.002	CcSEcCtD
Fomepizole—Anaemia—Etoposide—urinary bladder cancer	0.000704	0.002	CcSEcCtD
Fomepizole—Tachycardia—Fluorouracil—urinary bladder cancer	0.000699	0.00198	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—ATM—urinary bladder cancer	0.000692	0.00201	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CDK4—urinary bladder cancer	0.000689	0.002	CbGpPWpGaD
Fomepizole—Vertigo—Etoposide—urinary bladder cancer	0.000684	0.00194	CcSEcCtD
Fomepizole—Abdominal pain—Thiotepa—urinary bladder cancer	0.000684	0.00194	CcSEcCtD
Fomepizole—Body temperature increased—Thiotepa—urinary bladder cancer	0.000684	0.00194	CcSEcCtD
Fomepizole—Hypotension—Gemcitabine—urinary bladder cancer	0.00068	0.00193	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000677	0.00197	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC19A1—urinary bladder cancer	0.000672	0.00195	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—SLC19A1—urinary bladder cancer	0.000672	0.00195	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—KRAS—urinary bladder cancer	0.000669	0.00194	CbGpPWpGaD
Fomepizole—Hypotension—Fluorouracil—urinary bladder cancer	0.000669	0.0019	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000668	0.00194	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000667	0.00194	CbGpPWpGaD
Fomepizole—Tachycardia—Cisplatin—urinary bladder cancer	0.000662	0.00188	CcSEcCtD
Fomepizole—Convulsion—Etoposide—urinary bladder cancer	0.00066	0.00187	CcSEcCtD
Fomepizole—ADH1B—Metabolism—PRSS3—urinary bladder cancer	0.000655	0.0019	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PRSS3—urinary bladder cancer	0.000655	0.0019	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—UGT2B7—urinary bladder cancer	0.000655	0.0019	CbGpPWpGaD
Fomepizole—Eosinophilia—Methotrexate—urinary bladder cancer	0.000648	0.00184	CcSEcCtD
Fomepizole—Somnolence—Gemcitabine—urinary bladder cancer	0.000647	0.00184	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—GSTO2—urinary bladder cancer	0.000641	0.00186	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—NAT1—urinary bladder cancer	0.000641	0.00186	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP4B1—urinary bladder cancer	0.000641	0.00186	CbGpPWpGaD
Fomepizole—Somnolence—Fluorouracil—urinary bladder cancer	0.000636	0.00181	CcSEcCtD
Fomepizole—Hypotension—Cisplatin—urinary bladder cancer	0.000634	0.0018	CcSEcCtD
Fomepizole—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000633	0.0018	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000633	0.00184	CbGpPWpGaD
Fomepizole—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00063	0.00179	CcSEcCtD
Fomepizole—Pain—Gemcitabine—urinary bladder cancer	0.000623	0.00177	CcSEcCtD
Fomepizole—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000622	0.00177	CcSEcCtD
Fomepizole—Pain—Fluorouracil—urinary bladder cancer	0.000612	0.00174	CcSEcCtD
Fomepizole—Tachycardia—Etoposide—urinary bladder cancer	0.000607	0.00172	CcSEcCtD
Fomepizole—Eosinophilia—Epirubicin—urinary bladder cancer	0.000607	0.00172	CcSEcCtD
Fomepizole—CAT—Metabolism—SLC19A1—urinary bladder cancer	0.000605	0.00176	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000601	0.00175	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—RB1—urinary bladder cancer	0.000599	0.00174	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—urinary bladder cancer	0.000595	0.00173	CbGpPWpGaD
Fomepizole—Diarrhoea—Thiotepa—urinary bladder cancer	0.000592	0.00168	CcSEcCtD
Fomepizole—Decreased appetite—Cisplatin—urinary bladder cancer	0.00059	0.00167	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CYP4B1—urinary bladder cancer	0.000589	0.00171	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PRSS3—urinary bladder cancer	0.000589	0.00171	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000587	0.0017	CbGpPWpGaD
Fomepizole—Drowsiness—Methotrexate—urinary bladder cancer	0.000584	0.00166	CcSEcCtD
Fomepizole—Hypotension—Etoposide—urinary bladder cancer	0.000581	0.00165	CcSEcCtD
Fomepizole—Pain—Cisplatin—urinary bladder cancer	0.00058	0.00165	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000579	0.00168	CbGpPWpGaD
Fomepizole—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000576	0.00163	CcSEcCtD
Fomepizole—Dizziness—Thiotepa—urinary bladder cancer	0.000572	0.00162	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—HRAS—urinary bladder cancer	0.000569	0.00165	CbGpPWpGaD
Fomepizole—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000566	0.00161	CcSEcCtD
Fomepizole—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000561	0.00159	CcSEcCtD
Fomepizole—ADH1A—Metabolism—SLC19A1—urinary bladder cancer	0.000557	0.00162	CbGpPWpGaD
Fomepizole—Somnolence—Etoposide—urinary bladder cancer	0.000553	0.00157	CcSEcCtD
Fomepizole—Vomiting—Thiotepa—urinary bladder cancer	0.00055	0.00156	CcSEcCtD
Fomepizole—Drowsiness—Epirubicin—urinary bladder cancer	0.000546	0.00155	CcSEcCtD
Fomepizole—Rash—Thiotepa—urinary bladder cancer	0.000546	0.00155	CcSEcCtD
Fomepizole—Dermatitis—Thiotepa—urinary bladder cancer	0.000545	0.00155	CcSEcCtD
Fomepizole—ADH1A—Metabolism—PRSS3—urinary bladder cancer	0.000542	0.00158	CbGpPWpGaD
Fomepizole—Headache—Thiotepa—urinary bladder cancer	0.000542	0.00154	CcSEcCtD
Fomepizole—Decreased appetite—Etoposide—urinary bladder cancer	0.00054	0.00153	CcSEcCtD
Fomepizole—Body temperature increased—Cisplatin—urinary bladder cancer	0.000536	0.00152	CcSEcCtD
Fomepizole—Pain—Etoposide—urinary bladder cancer	0.000532	0.00151	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000528	0.00153	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000527	0.00153	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—TYMP—urinary bladder cancer	0.000523	0.00152	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMP—urinary bladder cancer	0.000523	0.00152	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000521	0.00151	CbGpPWpGaD
Fomepizole—Pharyngitis—Methotrexate—urinary bladder cancer	0.00052	0.00148	CcSEcCtD
Fomepizole—Nausea—Thiotepa—urinary bladder cancer	0.000514	0.00146	CcSEcCtD
Fomepizole—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000508	0.00144	CcSEcCtD
Fomepizole—Drowsiness—Doxorubicin—urinary bladder cancer	0.000506	0.00144	CcSEcCtD
Fomepizole—Visual impairment—Methotrexate—urinary bladder cancer	0.000505	0.00143	CcSEcCtD
Fomepizole—Bradycardia—Epirubicin—urinary bladder cancer	0.000499	0.00142	CcSEcCtD
Fomepizole—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000498	0.00141	CcSEcCtD
Fomepizole—Body temperature increased—Etoposide—urinary bladder cancer	0.000491	0.0014	CcSEcCtD
Fomepizole—Abdominal pain—Etoposide—urinary bladder cancer	0.000491	0.0014	CcSEcCtD
Fomepizole—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00049	0.00139	CcSEcCtD
Fomepizole—Pharyngitis—Epirubicin—urinary bladder cancer	0.000487	0.00138	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000478	0.00139	CbGpPWpGaD
Fomepizole—Dizziness—Fluorouracil—urinary bladder cancer	0.000473	0.00134	CcSEcCtD
Fomepizole—ADH1B—Metabolism—NAT2—urinary bladder cancer	0.000473	0.00137	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NAT2—urinary bladder cancer	0.000473	0.00137	CbGpPWpGaD
Fomepizole—Visual impairment—Epirubicin—urinary bladder cancer	0.000473	0.00134	CcSEcCtD
Fomepizole—CAT—Metabolism—TYMP—urinary bladder cancer	0.000471	0.00137	CbGpPWpGaD
Fomepizole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000464	0.00132	CcSEcCtD
Fomepizole—Vomiting—Gemcitabine—urinary bladder cancer	0.000463	0.00131	CcSEcCtD
Fomepizole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000462	0.00131	CcSEcCtD
Fomepizole—Rash—Gemcitabine—urinary bladder cancer	0.000459	0.0013	CcSEcCtD
Fomepizole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000459	0.0013	CcSEcCtD
Fomepizole—Headache—Gemcitabine—urinary bladder cancer	0.000456	0.00129	CcSEcCtD
Fomepizole—Flushing—Epirubicin—urinary bladder cancer	0.000455	0.00129	CcSEcCtD
Fomepizole—Vomiting—Fluorouracil—urinary bladder cancer	0.000455	0.00129	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000455	0.00132	CbGpPWpGaD
Fomepizole—Rash—Fluorouracil—urinary bladder cancer	0.000451	0.00128	CcSEcCtD
Fomepizole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000451	0.00128	CcSEcCtD
Fomepizole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00045	0.00128	CcSEcCtD
Fomepizole—Headache—Fluorouracil—urinary bladder cancer	0.000448	0.00127	CcSEcCtD
Fomepizole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000447	0.00127	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—NAT2—urinary bladder cancer	0.000445	0.00129	CbGpPWpGaD
Fomepizole—Back pain—Methotrexate—urinary bladder cancer	0.000441	0.00125	CcSEcCtD
Fomepizole—Visual impairment—Doxorubicin—urinary bladder cancer	0.000437	0.00124	CcSEcCtD
Fomepizole—ADH1A—Metabolism—TYMP—urinary bladder cancer	0.000434	0.00126	CbGpPWpGaD
Fomepizole—Nausea—Gemcitabine—urinary bladder cancer	0.000432	0.00123	CcSEcCtD
Fomepizole—Vomiting—Cisplatin—urinary bladder cancer	0.000431	0.00122	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.00043	0.00125	CbGpPWpGaD
Fomepizole—Vision blurred—Methotrexate—urinary bladder cancer	0.00043	0.00122	CcSEcCtD
Fomepizole—Rash—Cisplatin—urinary bladder cancer	0.000428	0.00121	CcSEcCtD
Fomepizole—Dermatitis—Cisplatin—urinary bladder cancer	0.000427	0.00121	CcSEcCtD
Fomepizole—CAT—Metabolism—NAT2—urinary bladder cancer	0.000426	0.00124	CbGpPWpGaD
Fomepizole—Diarrhoea—Etoposide—urinary bladder cancer	0.000425	0.00121	CcSEcCtD
Fomepizole—Nausea—Fluorouracil—urinary bladder cancer	0.000425	0.00121	CcSEcCtD
Fomepizole—Anaemia—Methotrexate—urinary bladder cancer	0.000422	0.0012	CcSEcCtD
Fomepizole—Flushing—Doxorubicin—urinary bladder cancer	0.000421	0.0012	CcSEcCtD
Fomepizole—Dysgeusia—Epirubicin—urinary bladder cancer	0.000418	0.00119	CcSEcCtD
Fomepizole—Back pain—Epirubicin—urinary bladder cancer	0.000413	0.00117	CcSEcCtD
Fomepizole—Dizziness—Etoposide—urinary bladder cancer	0.000411	0.00117	CcSEcCtD
Fomepizole—Vertigo—Methotrexate—urinary bladder cancer	0.00041	0.00116	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—EP300—urinary bladder cancer	0.00041	0.00119	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—RRM2—urinary bladder cancer	0.000409	0.00119	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—RRM2—urinary bladder cancer	0.000409	0.00119	CbGpPWpGaD
Fomepizole—Nausea—Cisplatin—urinary bladder cancer	0.000403	0.00114	CcSEcCtD
Fomepizole—Vision blurred—Epirubicin—urinary bladder cancer	0.000402	0.00114	CcSEcCtD
Fomepizole—Convulsion—Methotrexate—urinary bladder cancer	0.000395	0.00112	CcSEcCtD
Fomepizole—Vomiting—Etoposide—urinary bladder cancer	0.000395	0.00112	CcSEcCtD
Fomepizole—Anaemia—Epirubicin—urinary bladder cancer	0.000395	0.00112	CcSEcCtD
Fomepizole—Agitation—Epirubicin—urinary bladder cancer	0.000392	0.00111	CcSEcCtD
Fomepizole—ADH1A—Metabolism—NAT2—urinary bladder cancer	0.000392	0.00114	CbGpPWpGaD
Fomepizole—Rash—Etoposide—urinary bladder cancer	0.000392	0.00111	CcSEcCtD
Fomepizole—Dermatitis—Etoposide—urinary bladder cancer	0.000392	0.00111	CcSEcCtD
Fomepizole—Headache—Etoposide—urinary bladder cancer	0.000389	0.00111	CcSEcCtD
Fomepizole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000387	0.0011	CcSEcCtD
Fomepizole—Vertigo—Epirubicin—urinary bladder cancer	0.000384	0.00109	CcSEcCtD
Fomepizole—Back pain—Doxorubicin—urinary bladder cancer	0.000382	0.00108	CcSEcCtD
Fomepizole—ADH1B—Metabolism—ENO2—urinary bladder cancer	0.000378	0.0011	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ENO2—urinary bladder cancer	0.000378	0.0011	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—HPGDS—urinary bladder cancer	0.000378	0.0011	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—HPGDS—urinary bladder cancer	0.000378	0.0011	CbGpPWpGaD
Fomepizole—Vision blurred—Doxorubicin—urinary bladder cancer	0.000372	0.00106	CcSEcCtD
Fomepizole—Convulsion—Epirubicin—urinary bladder cancer	0.00037	0.00105	CcSEcCtD
Fomepizole—Nausea—Etoposide—urinary bladder cancer	0.000369	0.00105	CcSEcCtD
Fomepizole—CAT—Metabolism—RRM2—urinary bladder cancer	0.000368	0.00107	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTT1—urinary bladder cancer	0.000367	0.00107	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTT1—urinary bladder cancer	0.000367	0.00107	CbGpPWpGaD
Fomepizole—Anaemia—Doxorubicin—urinary bladder cancer	0.000365	0.00104	CcSEcCtD
Fomepizole—Agitation—Doxorubicin—urinary bladder cancer	0.000363	0.00103	CcSEcCtD
Fomepizole—Anxiety—Epirubicin—urinary bladder cancer	0.000362	0.00103	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—HPGDS—urinary bladder cancer	0.000356	0.00103	CbGpPWpGaD
Fomepizole—Vertigo—Doxorubicin—urinary bladder cancer	0.000355	0.00101	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	0.000351	0.00102	CbGpPWpGaD
Fomepizole—Hypotension—Methotrexate—urinary bladder cancer	0.000348	0.000988	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000347	0.00101	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTT1—urinary bladder cancer	0.000345	0.001	CbGpPWpGaD
Fomepizole—Shock—Epirubicin—urinary bladder cancer	0.000343	0.000973	CcSEcCtD
Fomepizole—Convulsion—Doxorubicin—urinary bladder cancer	0.000342	0.000972	CcSEcCtD
Fomepizole—CAT—Metabolism—HPGDS—urinary bladder cancer	0.000341	0.000989	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ENO2—urinary bladder cancer	0.000341	0.000989	CbGpPWpGaD
Fomepizole—Tachycardia—Epirubicin—urinary bladder cancer	0.00034	0.000966	CcSEcCtD
Fomepizole—ADH1A—Metabolism—RRM2—urinary bladder cancer	0.000339	0.000983	CbGpPWpGaD
Fomepizole—Anxiety—Doxorubicin—urinary bladder cancer	0.000335	0.000952	CcSEcCtD
Fomepizole—Somnolence—Methotrexate—urinary bladder cancer	0.000331	0.00094	CcSEcCtD
Fomepizole—CAT—Metabolism—GSTT1—urinary bladder cancer	0.00033	0.00096	CbGpPWpGaD
Fomepizole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000328	0.000931	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—NQO1—urinary bladder cancer	0.000327	0.000949	CbGpPWpGaD
Fomepizole—Hypotension—Epirubicin—urinary bladder cancer	0.000326	0.000924	CcSEcCtD
Fomepizole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000324	0.000919	CcSEcCtD
Fomepizole—Pain—Methotrexate—urinary bladder cancer	0.000318	0.000904	CcSEcCtD
Fomepizole—Shock—Doxorubicin—urinary bladder cancer	0.000317	0.000901	CcSEcCtD
Fomepizole—Tachycardia—Doxorubicin—urinary bladder cancer	0.000315	0.000893	CcSEcCtD
Fomepizole—ADH1A—Metabolism—HPGDS—urinary bladder cancer	0.000314	0.000911	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ENO2—urinary bladder cancer	0.000314	0.000911	CbGpPWpGaD
Fomepizole—Somnolence—Epirubicin—urinary bladder cancer	0.00031	0.000879	CcSEcCtD
Fomepizole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000307	0.000871	CcSEcCtD
Fomepizole—ADH1C—Metabolism—NQO1—urinary bladder cancer	0.000305	0.000886	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NQO1—urinary bladder cancer	0.000305	0.000886	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000304	0.000864	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GSTT1—urinary bladder cancer	0.000304	0.000883	CbGpPWpGaD
Fomepizole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000303	0.00086	CcSEcCtD
Fomepizole—Hypotension—Doxorubicin—urinary bladder cancer	0.000301	0.000855	CcSEcCtD
Fomepizole—Pain—Epirubicin—urinary bladder cancer	0.000298	0.000846	CcSEcCtD
Fomepizole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000294	0.000836	CcSEcCtD
Fomepizole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000294	0.000836	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—urinary bladder cancer	0.000293	0.000851	CbGpPWpGaD
Fomepizole—Somnolence—Doxorubicin—urinary bladder cancer	0.000287	0.000814	CcSEcCtD
Fomepizole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000285	0.000809	CcSEcCtD
Fomepizole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000284	0.000806	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	0.000281	0.000816	CbGpPWpGaD
Fomepizole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00028	0.000796	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000276	0.000802	CbGpPWpGaD
Fomepizole—Pain—Doxorubicin—urinary bladder cancer	0.000276	0.000783	CcSEcCtD
Fomepizole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000275	0.000782	CcSEcCtD
Fomepizole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000275	0.000782	CcSEcCtD
Fomepizole—CAT—Metabolism—NQO1—urinary bladder cancer	0.000275	0.000797	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.000273	0.000791	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.000273	0.000791	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000264	0.000749	CcSEcCtD
Fomepizole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000255	0.000724	CcSEcCtD
Fomepizole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000255	0.000724	CcSEcCtD
Fomepizole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000255	0.000723	CcSEcCtD
Fomepizole—ADH1B—Metabolism—GSTP1—urinary bladder cancer	0.000254	0.000739	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTP1—urinary bladder cancer	0.000254	0.000739	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NQO1—urinary bladder cancer	0.000253	0.000734	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.00025	0.000727	CbGpPWpGaD
Fomepizole—Dizziness—Methotrexate—urinary bladder cancer	0.000246	0.000699	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000239	0.000694	CbGpPWpGaD
Fomepizole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000238	0.000677	CcSEcCtD
Fomepizole—Vomiting—Methotrexate—urinary bladder cancer	0.000237	0.000672	CcSEcCtD
Fomepizole—ADH1C—Metabolism—TYMS—urinary bladder cancer	0.000236	0.000687	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—TYMS—urinary bladder cancer	0.000236	0.000687	CbGpPWpGaD
Fomepizole—Rash—Methotrexate—urinary bladder cancer	0.000235	0.000667	CcSEcCtD
Fomepizole—Dermatitis—Methotrexate—urinary bladder cancer	0.000235	0.000666	CcSEcCtD
Fomepizole—ADH1C—Metabolism—NCOR1—urinary bladder cancer	0.000234	0.000679	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTM1—urinary bladder cancer	0.000234	0.000679	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTM1—urinary bladder cancer	0.000234	0.000679	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NCOR1—urinary bladder cancer	0.000234	0.000679	CbGpPWpGaD
Fomepizole—Headache—Methotrexate—urinary bladder cancer	0.000233	0.000662	CcSEcCtD
Fomepizole—Dizziness—Epirubicin—urinary bladder cancer	0.00023	0.000654	CcSEcCtD
Fomepizole—CAT—Metabolism—GSTP1—urinary bladder cancer	0.000229	0.000665	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GPX1—urinary bladder cancer	0.000224	0.00065	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GPX1—urinary bladder cancer	0.000224	0.00065	CbGpPWpGaD
Fomepizole—Vomiting—Epirubicin—urinary bladder cancer	0.000222	0.000629	CcSEcCtD
Fomepizole—Nausea—Methotrexate—urinary bladder cancer	0.000221	0.000628	CcSEcCtD
Fomepizole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000221	0.000626	CcSEcCtD
Fomepizole—ADH1B—Metabolism—ERCC2—urinary bladder cancer	0.00022	0.000638	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ERCC2—urinary bladder cancer	0.00022	0.000638	CbGpPWpGaD
Fomepizole—Rash—Epirubicin—urinary bladder cancer	0.00022	0.000624	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.00022	0.000638	CbGpPWpGaD
Fomepizole—Dermatitis—Epirubicin—urinary bladder cancer	0.00022	0.000623	CcSEcCtD
Fomepizole—Headache—Epirubicin—urinary bladder cancer	0.000218	0.00062	CcSEcCtD
Fomepizole—Dizziness—Doxorubicin—urinary bladder cancer	0.000213	0.000605	CcSEcCtD
Fomepizole—CAT—Metabolism—TYMS—urinary bladder cancer	0.000213	0.000618	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTP1—urinary bladder cancer	0.000211	0.000612	CbGpPWpGaD
Fomepizole—CAT—Metabolism—NCOR1—urinary bladder cancer	0.00021	0.000611	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTM1—urinary bladder cancer	0.00021	0.000611	CbGpPWpGaD
Fomepizole—Nausea—Epirubicin—urinary bladder cancer	0.000207	0.000588	CcSEcCtD
Fomepizole—ADH1B—Metabolism—MTHFR—urinary bladder cancer	0.000207	0.0006	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—MTHFR—urinary bladder cancer	0.000207	0.0006	CbGpPWpGaD
Fomepizole—Vomiting—Doxorubicin—urinary bladder cancer	0.000205	0.000582	CcSEcCtD
Fomepizole—Rash—Doxorubicin—urinary bladder cancer	0.000203	0.000577	CcSEcCtD
Fomepizole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000203	0.000577	CcSEcCtD
Fomepizole—Headache—Doxorubicin—urinary bladder cancer	0.000202	0.000573	CcSEcCtD
Fomepizole—CAT—Metabolism—GPX1—urinary bladder cancer	0.000202	0.000585	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ERCC2—urinary bladder cancer	0.000198	0.000575	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TYMS—urinary bladder cancer	0.000196	0.000569	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTM1—urinary bladder cancer	0.000194	0.000563	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NCOR1—urinary bladder cancer	0.000194	0.000563	CbGpPWpGaD
Fomepizole—Nausea—Doxorubicin—urinary bladder cancer	0.000192	0.000544	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000189	0.000549	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000186	0.000541	CbGpPWpGaD
Fomepizole—CAT—Metabolism—MTHFR—urinary bladder cancer	0.000186	0.00054	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GPX1—urinary bladder cancer	0.000185	0.000539	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ERCC2—urinary bladder cancer	0.000182	0.000529	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000174	0.000504	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000171	0.000497	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—MTHFR—urinary bladder cancer	0.000171	0.000497	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PPARG—urinary bladder cancer	0.000168	0.000487	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PPARG—urinary bladder cancer	0.000168	0.000487	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CREBBP—urinary bladder cancer	0.000161	0.000467	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CREBBP—urinary bladder cancer	0.000161	0.000467	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PPARG—urinary bladder cancer	0.000151	0.000438	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000146	0.000425	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CREBBP—urinary bladder cancer	0.000145	0.000421	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PPARG—urinary bladder cancer	0.000139	0.000403	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	0.000139	0.000403	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NAT1—urinary bladder cancer	0.000139	0.000403	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CREBBP—urinary bladder cancer	0.000133	0.000387	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—urinary bladder cancer	0.000132	0.000383	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—urinary bladder cancer	0.000132	0.000383	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	0.000127	0.000369	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—urinary bladder cancer	0.000119	0.000345	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000116	0.000336	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTEN—urinary bladder cancer	0.000115	0.000334	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTEN—urinary bladder cancer	0.000115	0.000334	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	0.000114	0.000332	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.00011	0.000319	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.00011	0.000319	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—EP300—urinary bladder cancer	0.00011	0.000318	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—EP300—urinary bladder cancer	0.00011	0.000318	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—urinary bladder cancer	0.000109	0.000317	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	0.000108	0.000314	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	0.000105	0.000306	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTEN—urinary bladder cancer	0.000103	0.000301	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.0001	0.000291	CbGpPWpGaD
Fomepizole—CAT—Metabolism—EP300—urinary bladder cancer	9.87e-05	0.000287	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTEN—urinary bladder cancer	9.52e-05	0.000277	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—EP300—urinary bladder cancer	9.08e-05	0.000264	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	9.03e-05	0.000262	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	8.53e-05	0.000248	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMP—urinary bladder cancer	8.41e-05	0.000244	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	8.31e-05	0.000241	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NAT2—urinary bladder cancer	7.61e-05	0.000221	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMP—urinary bladder cancer	6.65e-05	0.000193	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—RRM2—urinary bladder cancer	6.57e-05	0.000191	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ENO2—urinary bladder cancer	6.08e-05	0.000177	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	6.08e-05	0.000177	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NAT2—urinary bladder cancer	6.01e-05	0.000175	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	5.9e-05	0.000171	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—RRM2—urinary bladder cancer	5.19e-05	0.000151	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NQO1—urinary bladder cancer	4.9e-05	0.000142	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	4.81e-05	0.00014	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ENO2—urinary bladder cancer	4.81e-05	0.00014	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.66e-05	0.000135	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	4.09e-05	0.000119	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.87e-05	0.000112	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMS—urinary bladder cancer	3.8e-05	0.00011	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	3.76e-05	0.000109	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	3.76e-05	0.000109	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GPX1—urinary bladder cancer	3.6e-05	0.000104	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	3.53e-05	0.000103	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	3.32e-05	9.64e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.23e-05	9.38e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3e-05	8.72e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.97e-05	8.62e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.97e-05	8.62e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.84e-05	8.26e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.79e-05	8.11e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PPARG—urinary bladder cancer	2.69e-05	7.82e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.62e-05	7.62e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.59e-05	7.51e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.13e-05	6.18e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	2.12e-05	6.15e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.04e-05	5.94e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.85e-05	5.36e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.76e-05	5.12e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.67e-05	4.86e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.46e-05	4.24e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.39e-05	4.04e-05	CbGpPWpGaD
